{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:55:15Z","timestamp":1791176115961,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":2629,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24NS050606"],"award-info":[{"award-number":["U24NS050606"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["MNM1 2010-14580"],"award-info":[{"award-number":["MNM1 2010-14580"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013465","name":"French Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ajpath.2012.06.034","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T17:56:10Z","timestamp":1344621370000},"page":"1402-1413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Antibodies to Gliomedin Cause Peripheral Demyelinating Neuropathy and the Dismantling of the Nodes of Ranvier"],"prefix":"10.1016","volume":"181","author":[{"given":"J\u00e9r\u00f4me J.","family":"Devaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2012.06.034_bib1","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2012.06.034_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ana.410090704","article-title":"Pathology of the Guillain-Barr\u00e9 syndrome","volume":"9","author":"Prineas","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/jnnp.48.3.239","article-title":"The pathological basis of conduction block in human neuropathies","volume":"48","author":"Feasby","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ajpath.2012.06.034_bib4","first-page":"19","article-title":"Guillain-Barr\u00e9 syndrome: an ultrastructural study of peripheral nerve in 65 patients","volume":"6","author":"Brechenmacher","year":"1987","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/mus.880150506","article-title":"Sural nerve biopsies in Guillain-Barr\u00e9 syndrome: axonal degeneration and macrophage-associated demyelination and absence of cytomegalovirus genome","volume":"15","author":"Hughes","year":"1992","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2012.06.034_bib6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/jnnp.52.7.857","article-title":"A fulminant case of Guillain-Barr\u00e9 syndrome: topographic and fibre size related analysis of demyelinating changes","volume":"52","author":"Kanda","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ajpath.2012.06.034_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/jnnp.55.11.1079","article-title":"Pseudoaxonal Guillain-Barr\u00e9 syndrome: severe demyelination mimicking axonopathy: a case with pupillary involvement","volume":"55","author":"Fuller","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ajpath.2012.06.034_bib8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib9","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/brain\/awg207","article-title":"Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barr\u00e9 syndrome","volume":"126","author":"Wanschitz","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.ajpath.2012.06.034_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1212\/WNL.54.1.33","article-title":"Physiologic-pathologic correlation in Guillain-Barr\u00e9 syndrome in children","volume":"54","author":"Lu","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2012.06.034_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410300205","article-title":"Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system","volume":"30","author":"Stoll","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.ajpath.2012.06.034_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/brain\/awq372","article-title":"Neurofascin as target of autoantibodies in Guillain-Barr\u00e9 syndrome","volume":"134","author":"Pruss","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ajpath.2012.06.034_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/brain\/awn281","article-title":"Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis","volume":"132","author":"Lonigro","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ajpath.2012.06.034_bib15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ceb.2008.09.007","article-title":"Molecular mechanisms of node of Ranvier formation","volume":"20","author":"Susuki","year":"2008","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1083\/jcb.200612139","article-title":"Secreted gliomedin is a perinodal matrix component of peripheral nerves","volume":"177","author":"Eshed","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib17","doi-asserted-by":"crossref","first-page":"10647","DOI":"10.1074\/jbc.M611339200","article-title":"Cleavage and oligomerization of gliomedin, a transmembrane collagen required for node of Ranvier formation","volume":"282","author":"Maertens","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.06.034_bib18","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1083\/jcb.135.5.1355","article-title":"Molecular composition of the node of Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin (mucin+ third FNIII domain-) and NrCAM at nodal axon segments","volume":"135","author":"Davis","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.neuron.2010.02.004","article-title":"A glial signal consisting of gliomedin and NrCAM clusters axonal Na+ channels during the formation of nodes of Ranvier","volume":"65","author":"Feinberg","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ajpath.2012.06.034_bib20","doi-asserted-by":"crossref","first-page":"42426","DOI":"10.1074\/jbc.M111.266353","article-title":"Fibronectin type III-like domains of neurofascin-186 protein mediate gliomedin binding and its clustering at the developing nodes of Ranvier","volume":"286","author":"Labasque","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.06.034_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuron.2005.10.019","article-title":"Neurofascins are required to establish axonal domains for saltatory conduction","volume":"48","author":"Sherman","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.ajpath.2012.06.034_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0960-9822(01)00680-7","article-title":"Neurofascin is a glial receptor for the paranodin\/Caspr-contactin axonal complex at the axoglial junction","volume":"12","author":"Charles","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib23","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1083\/jcb.200712154","article-title":"Glial and neuronal isoforms of Neurofascin have distinct roles in the assembly of nodes of Ranvier in the central nervous system","volume":"181","author":"Zonta","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuron.2005.06.026","article-title":"Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier","volume":"47","author":"Eshed","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.ajpath.2012.06.034_bib25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1471-4159.1982.tb07979.x","article-title":"Neuritogenic determinant of bovine P2 protein in peripheral nerve myelin","volume":"39","author":"Uyemura","year":"1982","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2012.06.034_bib26","doi-asserted-by":"crossref","first-page":"11215","DOI":"10.1523\/JNEUROSCI.3479-04.2004","article-title":"CNS myelin paranodes require Nkx6-2 homeoprotein transcriptional activity for normal structure","volume":"24","author":"Southwood","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2012.06.034_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0896-6273(00)80942-3","article-title":"Paranodin, a glycoprotein of neuronal paranodal membranes","volume":"19","author":"Menegoz","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.ajpath.2012.06.034_bib28","first-page":"115","article-title":"Demyelination and axonal degeneration in Lewis rat experimental allergic neuritis depend on the myelin dosage","volume":"59","author":"Hahn","year":"1988","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2012.06.034_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF00310924","article-title":"P2-peptide induced experimental allergic neuritis - a model to study axonal degeneration","volume":"82","author":"Hahn","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2010.07.010","article-title":"Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis","volume":"229","author":"Tran","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib31","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","article-title":"Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers","volume":"27","author":"Susuki","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2012.06.034_bib32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.expneurol.2011.11.039","article-title":"Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies","volume":"233","author":"Susuki","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib33","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/NEN.0b013e3181f3a5b1","article-title":"Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis","volume":"69","author":"Howell","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000050777","article-title":"A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barr\u00e9 syndrome","volume":"46","author":"Diener","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0165-5728(88)90177-4","article-title":"Role of therapeutic plasmapheresis in the acute Guillain-Barr\u00e9 syndrome","volume":"20","author":"McKhann","year":"1988","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","article-title":"Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial","volume":"7","author":"Hughes","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.56.4.445","article-title":"Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy","volume":"56","author":"Mendell","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2012.06.034_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","article-title":"Pathogenesis of Guillain-Barr\u00e9 syndrome","volume":"100","author":"Hughes","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib39","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib40","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barr\u00e9 syndrome","volume":"101","author":"Yuki","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2012.06.034_bib41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nbt859","article-title":"Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis","volume":"21","author":"Robinson","year":"2003","journal-title":"Nature Biotechnol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-5728(94)00164-J","article-title":"Synergy between antibody and P2-reactive T cells in experimental allergic neuritis","volume":"57","author":"Spies","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2012.06.034_bib43","first-page":"443","article-title":"Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin\/oligodendrocyte glycoprotein","volume":"130","author":"Linington","year":"1988","journal-title":"Am J Pathol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944012005159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944012005159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:01:41Z","timestamp":1762081301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944012005159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0002944012005159"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.06.034","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies to Gliomedin Cause Peripheral Demyelinating Neuropathy and the Dismantling of the Nodes of Ranvier","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}